Our findings demonstrate that patients with MDD comorbid with sleep disturbances exhibit elevated proportions of CD4+ T cells compared to those without such disturbance. These results suggest that targeted interventions addressing sleep disruption may contribute to restoring CD4+ T cell homeostasis, potentially offering a novel therapeutic strategy for MDD management.
Gao et al. (Thu,) studied this question.